Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

EVP, Head of R&D & CMO Inrig Jula exercised 32,395 shares at a strike of $8.93 and sold $2,785,021 worth of shares (44,674 units at $62.34) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 100,491 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.